Jump Financial, LLC I Mab Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$57.18 - $84.43 $310,944 - $459,130	-5,438 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$47.86 - $83.95 $260,262 - $456,520	5,438 New	5,438 $456,000
Q1 2021 May 17, 2021	SELL	$44.38 - $63.97 $348,649 - $502,548	-7,856 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$32.94 - $47.15 $84,194 - $120,515	2,556 Added 48.23%	7,856 $370,000
Q3 2020 Nov 13, 2020	BUY	$27.46 - $47.03 $145,538 - $249,259	5,300 New	5,300 $249,000

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $74.8M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.